comparemela.com

Latest Breaking News On - Adhoc - Page 11 : comparemela.com

EQS-Adhoc: learnd SE: market abuse (Market Abuse Regulation) Acquisition of Complete Energy Controls Ltd by learnd Limited

EQS-Ad-hoc: learnd SE / Key word(s): Takeover learnd SE: market abuse (Market Abuse Regulation) Acquisition of Complete Energy Controls Ltd by learnd Limited 02-May-2023 / 17:15 CET/CEST Disclosure

United kingdomJobst honigEnergy controls ltdAcquisition of complete energy controls ltdNews serviceDistribution servicesCompany contactMarket abuse regulationComplete energy controls ltdRegulatory announcementsCorporate newsGeneral standardRegulated unofficial market

EQS-Adhoc: Dexus Finance Pty Limited: Changes to Leadership team

EQS-Ad-hoc: Dexus Finance Pty Limited / Key word(s): Real Estate/Personnel Dexus Finance Pty Limited: Changes to Leadership team 01-May-2023 / 01:57 CET/CEST Disclosure of an inside information acc.

New south walesKevin georgeRowena causleyLuke odonnellAndy collinsDarren steinbergBrett cameronDexus funds management ltdAustralian securities exchangeHead of officeNews serviceDexus funds managementGroup headHead of office portfolioDistribution servicesDexus finance pty limited key

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA Commercial Launch Progressing Ahead of Schedule

Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA Commercial Launch Progressing Ahead of Schedule 01-May-2023 / 07:00

Switzerland generalChris schellingCatherine dayRelief therapeutics holding sa keyRelief therapeutics holdingTherapeutics incDrug administrationInvestor relations communicationsNews serviceUniversity of washingtonAcer therapeutics incExchange commissionSwiss exchangeLaunch progressing aheadRelief therapeuticsMedicare part

Adhoc: IGEA Pharma N V : IGEA to get SIX approval to Annual Report 2022 disclosure

IGEA Pharma N.V. / Key word(s): Annual Results/Annual Results IGEA Pharma N.V.: IGEA to get SIX approval to Annual Report 2022 disclosure 01-May-2023 / 23:46 CET/CEST Release of an ad hoc announcement

Noord hollandPierpaolo ceraniNews serviceSwiss exchangeExchange regulationAnnual reportJoint ventureUnofficial market

Adhoc: Kinarus Therapeutics Holding AG: Kinarus Therapeutics Holding AG ( Kinarus ) receives deadline extension from SER for publication of its 2022 annual financial report

Kinarus Therapeutics Holding AG / Key word(s): Annual Results Kinarus Therapeutics Holding AG ('Kinarus') receives deadline extension from SER for publication of its 2022 annual financial report 28-Apr-2023

Alexander bauschChris maggosErnst youngKinarus therapeutics holding ag keyKinarus therapeutics holding agCohesion bureauExchange regulationKinarus therapeutics holdingSwiss exchangeTherapeutics holdingListing rules

vimarsana © 2020. All Rights Reserved.